Related Experiment Video
Updated: May 30, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
Anne Steininger1, Markus Möbs, Reinhard Ullmann
1Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Abstract:
The transcription factor E2A is essential for lymphocyte development. In this study, we describe a recurrent E2A gene deletion in at least 70% of patients with Sézary syndrome (SS), a subtype of T cell lymphoma. Loss of E2A results in enhanced proliferation and cell cycle progression via derepression of the protooncogene MYC and the cell cycle regulator CDK6. Furthermore, by examining the gene expression profile of SS cells after restoration of E2A expression, we identify several E2A-regulated genes that interfere with oncogenic signaling pathways, including the Ras pathway. Several of these genes are down-regulated or lost in primary SS tumor cells. These data demonstrate a tumor suppressor function of E2A in human lymphoid cells and could help to develop new treatment strategies for human lymphomas with altered E2A activity.
Insights
The E2A gene is frequently deleted in Sézary syndrome, a T cell lymphoma. Loss of E2A promotes cancer growth by increasing cell proliferation and impacting oncogenic signaling pathways.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- The transcription factor E2A is crucial for lymphocyte development.
- Sézary syndrome (SS) is an aggressive subtype of T cell lymphoma.
Purpose of the Study:
- To investigate the role of E2A in Sézary syndrome pathogenesis.
- To identify E2A-regulated genes involved in SS development.
Main Methods:
- Analysis of E2A gene status in SS patients.
- Gene expression profiling of SS cells.
- Restoration of E2A expression in SS cells.
Main Results:
- Recurrent E2A gene deletion found in at least 70% of SS patients.
- Loss of E2A enhances proliferation via MYC and CDK6 derepression.
- Identified E2A-regulated genes that inhibit oncogenic pathways like Ras, which are downregulated in SS.
Conclusions:
- E2A functions as a tumor suppressor in human lymphoid cells.
- Altered E2A activity is implicated in lymphoma development.
- Findings may inform new therapeutic strategies for lymphomas targeting E2A.
More Related Videos
11:50Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN
Published on: April 3, 2026
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...